幼淋巴细胞白血病：对重组干扰素α治疗有非常满意的反应。
Prolymphocytic leukemia: a very satisfactory response to treatment with recombinant interferon alpha.
作者信息
Vivaldi P, Garuti R, Rubertelli M, Mazzon C
机构信息
Dipartimento di Geriatria, Ospedale Generale S. Chiara, Trento, Italy.
出版信息
Haematologica. 1992 Mar-Apr;77(2):169-70.
PMID:1398302
Abstract
We report the case of a patient with prolymphocytic leukemia in whom a lengthy survival of 5 years was observed after treatment with splenic irradiation and chemotherapy. The patient obtained a surprising improvement with a significant reduction in the absolute count of the prolymphocytes and considerable reduction in splenomegaly after 3 months' therapy with interferon alpha.
摘要
我们报告了一例原淋巴细胞白血病患者的病例，该患者在接受脾脏照射和化疗后存活了5年。在用α干扰素治疗3个月后，患者的原淋巴细胞绝对计数显著减少，脾肿大也明显减轻，病情出现了惊人的改善。
Zotero 插件